Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823705 · ClinicalTrials.gov registry record · NA
Gastric Electrical Stimulation (GES) for the Treatment of Obesity
A NA study, sponsored by Medtronic Corporate Technologies and New Ventures.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01823705 is a NA study that has completed, run by Medtronic Corporate Technologies and New Ventures. The registered enrollment target is 32 participants.
The verdict
NCT01823705, a NA study, has completed, sponsored by Medtronic Corporate Technologies and New Ventures.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this feasibility study is to provide safety data on the implantable Exilis gastric electrical stimulation (GES) system, to individually adjust stimulation parameters to levels that are comfortable for implanted subjects during chronic daily treatment, and to collect data on acute gastrointestinal function and food intake responses to GES during in-clinic testing.
Interventions
- DEVICE Exilis Implantable Gastric Electrical Stimulation (GES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-03-29 |
| Est. Completion | 2017-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823705
The ClinicalTrials.gov registry entry for NCT01823705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Corporate Technologies and New Ventures, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exilis Implantable Gastric Electrical Stimulation (GES) is the first listed.
NCT01823705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01823705 about?
NCT01823705 is a clinical study titled "Gastric Electrical Stimulation (GES) for the Treatment of Obesity". The purpose of this feasibility study is to provide safety data on the implantable Exilis gastric electrical stimulation (GES) system, to individually adjust stimulation parameters to levels that are comfortable for implanted subjects during chronic daily treatment, and to collect data on acute gast...
What is the current status of trial NCT01823705?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2013-03-29. Estimated completion is 2017-01-13.
What interventions are being tested in trial NCT01823705?
The interventions under investigation include: Exilis Implantable Gastric Electrical Stimulation (GES) (DEVICE).
Who is sponsoring clinical trial NCT01823705?
This trial is sponsored by Medtronic Corporate Technologies and New Ventures, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.